Targeted Oncology
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly…
read moreAmerican Society of Hematology
Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11…
read moreMedPage Today
Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential…
read moreHemOnc Today
Multiple Myeloma regimens significantly less effective in real-world treatment settings In this study, researchers looked…
read moreHealio Hematology & Oncology News
Healio Hematology & Oncology News: Interviewed Dr. Berenson on his perspective on Abstract 1 &…
read moreHealthTree Foundation
Has built many patient programs and over 8 integrated software platforms to help blood cancer…
read moreOutcomes of Triple Class Refractory Multiple Myeloma Patients
| James Berenson, MD | ASH 2023 – video
read moreMedical Writing Bias in Myeloma Clinical Research
| James Berenson, MD | ASH 2023 – video
read moreAssessing Lenalidomide with Patients Progressing on JAK Inhibitors
| James Berenson, MD | ASH 2023 video
read moreVJHemOnc
VJHemOnc: (The Video Journal of Hematological Oncology) is an open-access video journal dedicated to providing…
read more